A practical guide to fit-for-purpose analytical development in an emerging cell therapy landscape
A panel of experienced professionals in cell therapy analytical development address day-to-day challenges in product development in a cell therapy landscape where both the cell types and the analytical tools used to characterize them are constantly evolving. The panel offers practical advice on how to navigate a changing regulatory landscape, as well as how to leverage the cutting edge in technological advancements for optimized product characterization and quality control.
Authors
- Jie Wei (ORCID: https://orcid.org/0000-0002-3495-9311)
- David A. Marshall (ORCID: https://orcid.org/0009-0004-0104-2402)
- Florian Durst
Institutions
- Resolve Therapeutics (United States) (US)
- RPX (United States) (US)
- Thermo Fisher Scientific (Germany) (DE)
Publication Details
- Journal
- Cell and Gene Therapy Insights
- Published
- 2025-06-18
- DOI
- https://doi.org/10.18609/cgti.2025.070
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00